Veloryx 2025: The defense transition is not yet in the numbers, and the cash is only buying time

Company Overview

Veloryx is still not a defense company in the operating sense of the term. It finished 2025 as a company whose historical business remained internal-combustion engines and generators, with no revenue, just $321k of cash on the balance sheet, and meaningful doubt about its ability to continue as a going concern. On top of those numbers, management built a new story: a pivot to border protection and homeland security, a refreshed management and board team, and a memorandum of understanding to acquire a profitable drone company. That is an interesting story, but it is still not a story that has reached the income statement.

What is working now is real enough. There is an engineering footprint in Germany and Poland, an engine activity that has not been shut down but is being redirected toward monetization through a third party, a new management team with defense credentials, and an acquisition target that for the first time would bring actual products, customers, and profitability into the frame. In other words, the company is no longer presenting only a pure technology vision. It is trying to connect an existing technical base to a defense platform that could generate revenue.

But this is also where a superficial reading goes wrong. Anyone reading the headlines around the HLS transition could assume Veloryx already owns an active defense business. It does not. As of the report date, the new HLS segment had no revenue, no products, no customers, no marketing activity, and no backlog inside Veloryx itself. That entire layer still sits at the level of intent, the new team, and the Euro Sol MOU. So the central economic question in 2025 is not whether the company picked an attractive defense theme. It is whether it has enough capital and enough time to turn that declaration into actual activity.

The active bottleneck is financing, not technology. The legacy engine activity still needs an outside partner to complete the move to serial production, and the Euro Sol deal also depends on financing, approvals, and a binding agreement. That is why 2025 is not a breakout year. It is a bridge year. If the acquisition closes and the first AQ150 pilot ships, the read on the company changes. If not, the capital that came in after the balance sheet mainly buys more time and more dilution.

The orientation map here needs to stay simple:

This chart is not just about cost cutting. It shows the company entered 2026 much smaller than the platform it carried a year earlier. Headcount fell from 63 to 28, and then to 26 near the report approval date. That is evidence of a real reset, but also evidence that the existing activity still does not provide a broad enough operating base to grow without fresh capital.

Events and Triggers

The move into defense happened fast, but not yet in reported economics

The big move at the end of 2025 was the board decision to change direction and reposition the company around border protection and homeland security. As part of that shift, the company changed its name, brought in Roy Bar-Gil as CEO, added Roni Numa as chairman and Tzvika Haimovich as director, and later appointed a new CFO set to start in early April 2026. This is not cosmetic. It is a near-complete reset of the leadership layer to fit a new thesis.

At the same time, the company did not shut down the engine activity and walk away from it. It is trying to move it onto a different path: a strategic cooperation with a third party that would fund the move to serial production, commit the capital required until commercialization, and in return leave Veloryx with royalties or a sale of the activity. That detail matters because it says management itself is not currently planning to fund full commercialization internally. Even in management's own framing, the engine business has moved from a growth narrative to a monetization narrative.

Euro Sol is the main trigger, but it is still not an owned asset

The main catalyst that could change the read faster than anything else is the memorandum of understanding with Euro Sol Aviation Solutions. This is already far more concrete than the general HLS repositioning. Management describes an Israeli, profitable defense company with more than 13 years of activity, four drone models, customers in Israel such as the Police, the Ministry of Defense, the IDF, MAFAT, Elbit Systems, and Next Vision, and international exposure in Morocco, Brazil, the Netherlands, and Japan.

That matters for two reasons. First, the identity of the customers changes the quality of the story. This is no longer a generic “we are entering defense” message, but an attempt to acquire a company with actual defense-facing customer exposure. Second, the figures disclosed around Euro Sol are the first time Veloryx is attaching itself to a target with revenue and profitability, which means this is also the first place investors can test whether the company can move from narrative to operating reality.

But this is also where the analysis needs to stay disciplined. The transaction is still non-binding. The structure is staged: NIS 13 million in the first step, another NIS 13 million within 90 days of closing or at another agreed date, and then a NIS 9 million preferred-share capital injection in nine monthly payments. There are also PUT and CALL mechanisms on the remaining shares after three years. So even if the deal closes, this is not a one-check bolt-on. It adds an ongoing financing commitment and an integration burden.

That chart shows why the deal is material. This is not a small add-on to an existing operating platform. It is a NIS 35 million commitment before any future option exercise, on a company that Veloryx still does not own. The transaction could transform the company if it closes, but it could also weigh on the structure if it requires aggressive financing.

There is also a disclosure-quality yellow flag around Euro Sol. The published numbers are not fully aligned:

This is not a trivial mismatch. If management wants Euro Sol to be read as the economic anchor of the defense transition, the disclosure layer around the target needs to be cleaner than it is today.

The cash that came after the balance sheet reduced pressure, but did not settle the question

The second major event cluster is financing. Throughout 2025 the company operated on loans, advance receipts, and commitments to issue shares and warrants. After the balance sheet there were two important developments: in February 2026 the full $9 million investment by the controlling shareholder was funded, and in March 2026 the board approved a private placement of NIS 19.501 million to nine qualified investors, against 13.0 million shares and 6.5 million warrants, plus 975 thousand warrants to the transaction adviser. But as of the annual report date, that placement still had not received exchange approval.

The implication cuts both ways. On the one hand, it would be wrong to read the end of 2025 as if the company was stuck forever with $321k and no funding path. Money did come in after the balance sheet, and the company has already been moving the structure. On the other hand, it would also be wrong to read that financing as if the liquidity issue is solved. Part of the money came at a significant dilution cost, part of it was still pending approvals, and the report still carries a going-concern warning. So the true short-term trigger is not the strategy announcement itself. It is whether the company can complete actual funding without widening the gap between corporate survival and shareholder-accessible value.

Efficiency, Profitability, and Competition

The bottom line looks worse in 2025, but not because the core cost base exploded again

The number that attracts attention is the $17.763 million annual loss. But that only tells half the story. In narrow operating terms, the company actually cut some of the burn. R&D expense fell to $8.129 million, down roughly 15% year over year. G&A dropped to $2.729 million, down about 19%. Operating loss improved from $13.692 million to $12.418 million.

What widened the annual loss was financing. Net finance expense jumped to $5.027 million, versus only $398k in 2024. The largest component was the remeasurement of the liability to issue shares and warrants, which created $5.093 million of finance expense, while the remeasurement of existing warrant liabilities contributed $616k of finance income. Other expenses of $1.176 million were mostly an impairment on right-of-use assets and fixed assets.

That is the accounting core of 2025. The operating loss is still large, but the deterioration in the headline bottom line came mainly from the cost of rescue financing and the capital-structure architecture, not from a parallel re-acceleration of engineering spend.

The second half shows the move from engines to financing stress

On a half-year basis the picture is even sharper. First-half 2025 loss was $6.963 million. The second half rose to $10.800 million. Yet R&D actually fell from $4.915 million in the first half to $3.124 million in the second half, and G&A fell from $1.623 million to $1.106 million. What changed was finance expense, which exploded from just $42k in the first half to $4.985 million in the second half.

So anyone trying to read 2025 as if the company simply “failed operationally” is missing the structure. The company is still far from revenue, but in 2025 the bigger problem was the price of time, not only the price of development.

Competition still cannot be read through the new defense segment

In HLS management already frames a competitive arena that includes large international names. That may sound impressive, but it is not yet competition at the product or customer level for Veloryx itself. The company still has no revenue or backlog there. So its competitive position cannot yet be measured through the new defense activity. If there is a moat, it will only be testable if Euro Sol closes and if the promised synergies actually start to work.

In engines, by contrast, there is still a technological proposition, but even there the gap between technology and revenue remains open. In November 2025, EnviroCharge informed the company that because of delays in the pilot timeline it would need to examine other alternatives, and would revisit a proof of concept only once the system was ready. That is the difference between an interesting product and actual commercialization. Until a customer moves from pilot to revenue, the advantage remains mostly on paper.

Cash Flow, Debt, and Capital Structure

Cash Flow

This is where the framing needs to be precise. I am using an all-in cash flexibility lens here, meaning how much cash remained after the period's actual cash uses. In 2025, operating cash flow burned $10.201 million. On top of that there were $68k of reported CAPEX, $324k of lease principal repayments, and $154k of lease interest cash. In other words, before new financing sources, the company consumed roughly $10.7 million of real cash in 2025.

That chart says two things at once. First, without fresh financing the company would not have reached year-end. Second, even with $7.663 million of positive financing cash flow in 2025, year-end cash still fell to just $321k, down nearly 88% from the end of 2024. That is exactly why the going-concern warning does not look dramatic. It looks like a straightforward reading of the balance sheet.

There is also one source of confusion that matters. Investing cash flow was positive at $467k, but that mainly came from net deposit withdrawals, not from an operating business that suddenly generated cash. So there is no hidden flexibility story here. There is another stone the company picked up off the floor to get through the year.

Debt and Funding Structure

Rather than classical bank debt, the center of gravity in 2025 was bridge financing and equity-linked obligations. In June 2025 the company received a $3 million loan from its controlling shareholder, bearing interest at prime plus 1.5%, with a conversion mechanism into shares if funding milestones were not met on time. That instrument says a lot about the situation: this was not ordinary debt raised against an operating business. It was time bought in a convertible form. By December 2025, the balance sheet already carried a $9.813 million liability to issue shares and warrants, plus a further $98k warrant liability.

That means most of the company's funding moved through quasi-equity, or very expensive equity, rather than internal cash generation. So the real question is not only how much money came in, but how much remains for common shareholders after that money is translated into shares, warrants, and obligations to issue more of them. That is also why the P&L became so sensitive to remeasurement.

Capital Structure

At year-end 2025, total assets stood at only $1.764 million, against $12.169 million of liabilities and a $10.405 million equity deficit. This is not a company with a mildly stretched balance sheet. It is a company relying almost entirely on the ability to keep bringing in outside capital and on the hope that an acquired or monetized activity will arrive before the next funding hole opens.

This is also where created value needs to be separated from accessible value. If the controlling shareholder puts in $9 million, and if the market later approves another NIS 19.5 million placement, that does not automatically make common shareholders richer. Some of that value is created only because the company does not fail immediately. Some of it comes with dilution. And another part depends on whether management can convert that capital into an operating asset at all.

Forecast and What Comes Next

Finding one: 2026 stands or falls first on Euro Sol. If the deal is signed and financed, Veloryx moves in one step from a no-revenue company to a platform with a revenue-producing defense activity. If it is not signed, the whole HLS layer remains largely declarative.

Finding two: even if Euro Sol closes, the engine business does not disappear. AQ150 is still supposed to reach a first pilot in Q2 2026, and the company has already produced two engines and one generator, with four more engines and two more generators in advanced production. So even after the pivot, the engine activity remains a material option, but not one management plans to fund fully on its own.

Finding three: this is a bridge year with a double proof test. One test is financial, to close the deal and complete the funding without creating another capital-structure spiral. The second is operational, to show the legacy platform is not stalled indefinitely and that there is a real path to commercialization or a clear monetization route.

Finding four: the market is likely to react in the near term more to funding announcements and Euro Sol progress than to the 2025 numbers themselves. Short interest is effectively negligible, so skepticism is not being expressed through short positioning. It is being expressed through financing terms, warrant overhang, and the need to turn announcements into agreements.

What has to happen in Euro Sol

If Euro Sol is the heart of the thesis, it needs to be measured hard. The company needs a binding agreement, closed financing, and then the ability to preserve Euro Sol as an independent profit unit rather than dilute it through premature integration. The figures disclosed around the target show NIS 16 million of revenue in 2024 and NIS 20 million in 2025, but also a decline in EBITDA margin from 22% to 17%. So even if the published numbers are taken at face value, this is not a frictionless cash machine. It is a business with sales and profitability, but also with an open question around quality and mix in the latest year.

That chart captures the opportunity and the friction together. Revenue grew 25%, but EBITDA margin fell by 5 percentage points. So even in the constructive case where the deal closes, 2026 will not be a year of “we bought profitability and we are done.” It will be a year of testing revenue quality and margin resilience under integration and expansion.

What has to happen in engines

Even if the market prefers to focus on Euro Sol, the remaining engine activity cannot be ignored. As of the report date the company had produced two engines and one generator, had four more engines and two generators in advanced production, and was targeting a first system shipment for pilot testing in Q2 2026. That means it is still wrong to write the activity off entirely. But it is equally wrong to treat it as near-commercial without caveats. Already in November 2025, a key potential partner signaled it would consider alternatives because of delays in the pilot timetable.

The bottleneck here is clear: either the company shows the technology moving on time from pilot to commercialization, or it has to rely on a third party that funds the path and captures part of the future economics in return. So here too, created value is not automatically fully retained inside Veloryx.

What kind of year is this

For now, 2026 looks like a funded bridge year, not a breakout year. It can become a proof year if two things happen together: Euro Sol closes on clear terms, and the company shows commercial proof for the engine platform or a clean alternative route through royalties or a sale. If only one of those happens, the read remains partial. If both slip, the market will return quickly to the oldest question in the story: how much time remains until the next financing need.

Risks

The first risk is that the deal remains a good story

The Euro Sol memorandum is not binding, and the company itself says completion depends on due diligence, commercial agreements, financing, regulatory approvals, and corporate approvals. Anyone already underwriting an immediate move into a defense operating company is putting a transaction into the thesis that has not happened yet.

The second risk is that financing solves months, not the model

The going-concern warning does not disappear simply because money was raised or approved after the balance sheet. It disappears only if that money becomes a self-supporting model. Right now those are still different things. There are inflows, allocations, and commitments, but there is still no operating business producing cash.

The third risk is dilution and shareholder-accessible value

Even if the strategic move into defense works, common shareholders still need to ask how much of the value will remain theirs. 2025 already showed that capital is arriving through a heavy layer of shares, warrants, and obligations to issue more of them. If more capital is needed to close Euro Sol, fund ongoing activity, and carry AQ150 toward commercialization, dilution may end up being a central economic feature of the story rather than a footnote.

The fourth risk is that disclosure is not fully settled yet

When the same deal is described across different disclosure layers with figures that do not fully reconcile, and when some of the key target numbers are unaudited, investors carry not only business risk but also analytical disclosure risk. This is not a dramatic legal point. It is a real valuation point. It makes it harder to know what exactly is being bought, at what pace, and with what earnings quality.

Conclusions

Veloryx finished 2025 as a transition company. It is no longer just the old Aquarius engine story, but it is also not yet a functioning HLS platform. What supports the thesis today is a serious attempt to buy a real defense activity, alongside capital injections that prevent an immediate stop. What prevents the read from becoming cleaner is that revenue is still not there, the central transaction is still not closed, and the capital structure has already exacted a heavy cost.

Current thesis in one line: Veloryx is trying to move from a no-revenue engine company to a defense company through acquisition, but as of 2025 the reported entity is still living on financing, dilution, and future execution rather than on operating proof.

What changed versus the old reading is clear: instead of looking only at the linear engine and AQ150, investors now need to look at capital allocation, acquisition execution, and whether the company can buy itself a real operating base. The strongest counter-thesis is that even if 2025 looks full of yellow flags, a combination of Euro Sol and a royalty or sale route for the engines could make this look in hindsight like a smart transition year, one in which the company bought time and an operating asset without fully writing off the older technology option.

What can change the market reading in the short to medium term is also clear: a binding Euro Sol agreement, clean completion of the post-balance-sheet capital actions, and a credible update on the first AQ150 pilot. That matters because the question at Veloryx is no longer whether there is a vision. It is whether management can convert that vision into revenue before the next financing event once again becomes the main story.

For the thesis to strengthen over the next two to four quarters, the company has to show that the move into defense closes on actual contractual and financing terms, and that the engine platform advances toward a pilot or a clear monetization path. What weakens the thesis is just as obvious: delay in Euro Sol, delay in funding completion, or another erosion that leaves the company with plenty of strategy and too little time.